Company Filing History:
Years Active: 2000-2009
Title: Mary Jackson: Pioneering Innovator in Mycobacterial Research
Introduction
Mary Jackson is a distinguished inventor based in Paris, France. She has made significant contributions to the field of mycobacterial research, holding a total of 10 patents. Her work focuses on innovative methods for combating mycobacterial infections, which are critical in the fight against diseases such as tuberculosis.
Latest Patents
Among her latest patents is the invention related to the desaturase antigen of Mycobacterium tuberculosis. This patent provides antibodies that bind to the DES protein, which is essential for the survival of mycobacteria. Another notable patent involves a process for producing a recombinant protein in a mycobacterial host using plasmid pJAM2. This invention highlights a novel mycobacterial protein named DES, which shares significant amino acid sequence homology with soluble stearoyl-ACP desaturases. The findings from allelic exchange experiments indicate that the des gene may be crucial for mycobacterial survival. The unique structure of the DES protein and its expression in vivo suggest that it could serve as a new target for designing anti-mycobacterial drugs. Additionally, her inventions provide methods for screening molecules that can inhibit the DES enzyme activity, aiding in the identification of antibiotic molecules capable of inhibiting mycobacterial growth.
Career Highlights
Mary Jackson is currently affiliated with the Institut Pasteur, where she continues her groundbreaking research. Her work has garnered attention for its potential impact on public health, particularly in developing new treatments for mycobacterial infections.
Collaborations
Throughout her career, Mary has collaborated with notable colleagues, including Brigitte Gicquel and Christophe Guilhot. These partnerships have further enhanced her research and contributed to the advancement of knowledge in her field.
Conclusion
Mary Jackson's innovative work in mycobacterial research exemplifies the importance of scientific inquiry in addressing global health challenges. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.